July 19th 2024
A recent case series reviewed the treatment patterns and effects of therapies on 89 pediatric patients with CCD.
PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa
View More
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Off-label treatment with biologics effective for treating certain skin diseases
February 1st 2012Biologic drugs have proven to be of benefit for diseases where there is no indicated treatment, such as for immunobullous diseases. "Pemphigus vulgaris with rituximab (Rituxan, Genentech) has been a major advance, although this is not a formally approved indication for the drug," says Alan Menter, M.D., chief, dermatology, and chairman, residency program, Baylor University Medical Center, Dallas.
Infants with severe atopic dermatitis require team approach
February 1st 2012The unique needs of infants with severe atopic dermatitis require special attention. As such, says Mary Wu Chang, M.D., associate clinical professor of dermatology and pediatrics, University of Connecticut School of Medicine, "This is not something you can handle in a 15-minute visit."
Segmental pigmentation not associated with systemic manifestations, study finds
September 1st 2011Although patterned pigmentation in children can include a variety of clinical findings involving neurologic, musculoskeletal and cardiac abnormalities, most localized pigmentary disorders are not associated with systemic manifestations, according to pediatric dermatologist James Treat, M.D., University of Pennsylvania School of Medicine, Philadelphia.
Pediatric literature gives insight on new therapies for children
September 1st 2011Recent publications in pediatric literature are driving practice changes relative to conditions ranging from Kawasaki disease to child abuse to hemangiomas. Perhaps the most important recent pediatric publication many dermatologists may have missed addresses evaluating abuse versus accidental trauma in infants and young children, says Robert Sidbury, M.D., M.P.H., chief of pediatric dermatology and associate professor of pediatrics, Seattle Children's Hospital.
UV photography findings correlate with melanoma risk factors in children
August 1st 2011Results of a study in adolescents showing a correlation between the severity of sun damage in ultraviolet (UV) photographs and phenotypic risk factors for malignant melanoma provides further support for using UV photography in sun-protection interventions, according to Ryan G. Gamble, M.D., who spoke at the 2011 annual meeting of the Society for Investigative Dermatology.
Port wine stains clear faster with shorter pulsed dye laser treatment intervals
June 1st 2011Pulsed dye laser (PDL) treatment for infants with port wine stains (PWS) should be performed early and often, according to research conducted by dermatologic surgeons from the Laser & Skin Surgery Center of New York.
Multi-pronged strategy controls recalcitrant dermatitis in children
June 1st 2011Dermatitis in children can be challenging to treat, particularly when commonly used treatment regimens fail. According to one expert, a multi-pronged treatment strategy is the best approach to help clear symptoms and control disease.
Therapies for infantile hemangiomas need more clinical studies
May 1st 2011Despite recent advances, topical and systemic treatments for infantile hemangiomas need more randomized, controlled trials to help guide treatment decisions. Topical medications generally work best for localized, superficial hemangiomas, says Maria Garzon, M.D., professor of clinical dermatology and clinical pediatrics, Columbia University, New York.
Continuing medical education changes include physician self-evaluation
April 1st 2011Physicians immersed in the world of continuing medical education (CME) say big changes are happening. And doctors of all specialties, including dermatology, will be affected by the emerging CME focus: individual outcomes improvement.
Off-label propranolol for pediatric hemangiomas carries risks
April 1st 2011Determining the proper course of treatment of hemangiomas in pediatric patients can be difficult, as clinical data are sparse. Propranolol has become increasingly popular for off-label treatment, but it comes with significant risks, says Beth A. Drolet, M.D., professor of pediatrics and dermatology, vice chairwoman of dermatology, Medical College of Wisconsin, Milwaukee.
Physicians disagree on appropriate age for laser treatment of port wine stains
April 1st 2011After more than 20 years of widespread use, pulsed-dye lasers remain the therapy of choice in treating port wine stains in children and infants. Still, there have been no significant developments in recent years, and there is some disagreement regarding when treatment of port wine stains should begin.
Suspected pediatric melanomas should be biopsied as they would be in adults
April 1st 2011Pediatric melanomas are uncommon, but because melanoma is not always as easily diagnosed in children as in adults, it is critical to perform biopsies for pediatric patients just as one would for adults, an expert says.
Children susceptible to bedbug, lice infestations
April 1st 2011Pediatric patients are threatened by infestations such as bedbugs, head lice and scabies, so parents need to be vigilant of these risks, according to the chief of the division of pediatric dermatology at the Children’s Hospital of Pittsburgh.